Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Baylor Genetics | RCV001029950 | SCV001529266 | uncertain significance | Townes-Brocks syndrome 1 | 2018-02-07 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
| Victorian Clinical Genetics Services, |
RCV001029950 | SCV005086043 | pathogenic | Townes-Brocks syndrome 1 | 2024-10-08 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Townes-Brocks syndrome (MIM#107480) and Townes-Brocks branchiootorenal-like syndrome (MIM#107480). NMD escape has been demonstrated for a single PTC in the 5' end of exon 2, where dominant negative or gain of function is a suggested mechanism (PMID: 20301618). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Pathogenic variants within the 5' end exon 2 hot spot region appear to be associated with a more severe outcome than pathogenic variants towards the 3' end in exon 2 (PMID: 20301618). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic in a heterozygous individual with Townes-Brocks syndrome (PMID: 32656166). This variant has also been reported as likely pathogenic and VUS in ClinVar. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1204 - This variant has been shown to be de novo in the proband (parental status confirmed). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
| Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV001029950 | SCV001192748 | likely pathogenic | Townes-Brocks syndrome 1 | 2019-06-28 | no assertion criteria provided | clinical testing |